-
1 Comment
Lipocine Inc is currently in a long term downtrend where the price is trading 7.7% below its 200 day moving average.
From a valuation standpoint, the stock is 77.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 294.2.
Lipocine Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 37.0% to $-5M since the same quarter in the previous year.
Finally, its free cash flow fell by 11.4% to $-4M since the same quarter in the previous year.
Based on the above factors, Lipocine Inc gets an overall score of 1/5.
| ISIN | US53630X1046 |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
| Exchange | F |
| CurrencyCode | EUR |
| Beta | 0.93 |
|---|---|
| Dividend Yield | 0.0% |
| Market Cap | 21M |
| PE Ratio | None |
| Target Price | 4.75 |
Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders. Its lead product candidate is TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. The company's pipeline candidates also include LPCN 1154 for postpartum depression; LPCN 2101 for women with epilepsy; and LPCN 1148, a novel prodrug of testosterone, testosterone laurate for the management of decompensated cirrhosis. It also develops LPCN 1144, an oral prodrug of androgen receptor modulator for the treatment of non-cirrhotic non-alcoholic steatohepatitis, which has completed Phase II testing; LPCN 1111, an oral TRT product of testosterone tridecanoate for once daily dosing, which has completed Phase II clinical testing; and LPCN 1107, an oral hydroxy progesterone caproate product for the prevention of recurrent preterm birth. Lipocine Inc. is headquartered in Salt Lake City, Utah.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2VT.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
